Rheumatic disorders associated with immune checkpoint inhibitors in patients with cancer—clinical aspects and relationship with tumour response: a single-centre prospective cohort studyMarie Kostine, Thierry Schaeverbeke, L. Rouxel et al.|Annals of the Rheumatic Diseases|2017Cited by 302
Baseline co-medications may alter the anti-tumoural effect of checkpoint inhibitors as well as the risk of immune-related adverse eventsMarie Kostine, Thierry Schaeverbeke, Eleonora Mauric et al.|European Journal of Cancer|2021Cited by 93
OX40L/OX40 axis impairs follicular and natural Treg function in human SLEC. Jacquemin, Patrick Blanco, Jean‐François Augusto et al.|JCI Insight|2018Cited by 88
Clonal hematopoiesis driven by chromosome 1q/MDM4 trisomy defines a canonical route toward leukemia in Fanconi anemiaMarie Sébert, Éliane Gluckman, Stéphanie Gachet et al.|Cell stem cell|2023Cited by 75
Post-transplant cyclophosphamide versus antithymocyte globulin in patients with acute myeloid leukemia in first complete remission undergoing allogeneic stem cell transplantation from 10/10 HLA-matched unrelated donorsÉolia Brissot, Mohamad Mohty, Annalisa Ruggeri et al.|Journal of Hematology & Oncology|2020Cited by 68